Sarepta Therapeutics (SRPT) has issued an announcement.
Sarepta Therapeutics, Inc. has expanded its 2024 Employment Commencement Incentive Plan, adding 500,000 more shares for issuance, bringing the total to over 6 million shares. Additionally, the company’s annual stockholder meeting saw the reelection of its board of directors, approval of executive compensation, and the ratification of KPMG as its independent auditor for the year. This reflects robust participation from shareholders, with over 85% of eligible shares casting votes, indicating a strong interest in the company’s governance and future prospects.
For an in-depth examination of SRPT stock, go to TipRanks’ Stock Analysis page.
